Thank you expressing interest in our study. At this point, we not accepting additional participants, (unless you have filled out a survey previously and have returned to attest to your prior use of galantamine) due to our limited supplies of galantamine and placebo capsules. However, please fill out this survey, and we will contact you if we reopen the study to additional participants. Thank you!
Scott Sparrow, Principal Investigator
Exploring the Impact of the Effects of the Supplement Galantamine Paired with Dream Reliving and Meditation on Recalled Dreams
University of Texas Rio Grande Valley IRB# 907-90991
This survey is being conducted by:
Principal Investigator Gregory Scott Sparrow, EdD
Professor at The University of Texas-Rio Grande Valley
Co-PI Ralph Carlson, PhD
Professor The University of Texas-Rio Grande Valley
In consultation with Ryan Hurd, MA
Lecturer in Psychology and Holistic Studies
John F. Kennedy University
This study builds on an earlier study conducted (Sparrow, Hurd, and Carlson, 2016) (IRB# 2014-119-1)
In order to participate in this study, you must have first used galantamine on your own, and suffered no ill effects. Galantamine is known to produce mild side effects in some people, including stomach upset and nausea if taken on an empty stomach, and headaches.
After you have attested to the fact that you have used galantamine without suffering any ill effects, and consented to participation (by clicking on the "Yes"to both statements below), the study will involve eight days of dream recording spaced at least three days apart (with some leeway to accommodate your schedule) following a middle-of-the-night awakening, during which you will be asked to engage in 1) no activity before returning to bed, 2) no activity after ingesting capsules and then returning to bed, 3) meditation/dream reliving (M/DR) only before returning to bed, 4) M/DR after ingesting capsules, then returning to bed. In addition to the middle-of-the-night awakening/activity, the study will involve filling out a daily questionnaire which includes space for including any dreams from the night.
There will be a need for a degree of deception in order to determine the actual effects of galantamine. That is, Each S will receive active (galantamine) and inactive (placebo composed of cornstarch only) capsules as part of the research packet. Each participant will have color-coded]
'+ packets with identical-appearing capsules that either contain galantamine and cornstarch, or only cornstarch. While each S will participate in the same number of active and placebo conditions, the actual condition on a given night will be randomly assigned ahead of time, and unknown at the time of the study by researchers and participants for the reasons of research validity.
Participation in this research is completely voluntary.
You must be at least 21 years old to participate. If you are not 21 or older, please do not complete the survey.
You will be asked to ingest capsules that will contain 8 mg of galantamine on some nights, and a placebo on other nights. Since galantamine can produce mild side effects, to be completely safe we are only allowing participants in this study who have taken it previously. If you have any concerns about ingesting it, please confer with your physician. Your consent below will include an attestation that you have taken the supplement before, and are aware of its effects, if any.
We will need your name and physical address so we can send you a research packet that will include instructions as well as the galantamine and placebo capsules that will be used in the study. We will keep your identifying information in a key that will remain separate from the dataset, and we will use only a participant # to identify your dreams and survey responses. The key that will connect your identity with your data will be kept by Dr. Sparrow in his locked office at UTRGV.
Although all dreams and survey responses that we receive will be treated confidentially and stored on a secure server, we are unable to guarantee the security of the computer on which you choose to enter your responses, nor can we guarantee the security of your data against server security breaches. We want you to be aware that certain technologies exist that can be used to monitor or record data that you enter and/or websites that you visit.
Any data will only be available to those directly involved in this study. De-identified data may be shared with other researchers in the future, but as stated above, will not contain information about your identity.
This research has been reviewed and approved by the Institutional Review Board for Human Subjects Protection (IRB) (Project # 907-90991). If you have any questions about your rights as a participant, or if you feel that your rights as a participant were not adequately met by the researcher, please contact the UTRGV IRB at 956-665-2889 or at firstname.lastname@example.org. You are also invited to provide anonymous feedback to the IRB by visiting www.utrgv.edu/IRBfeedback. Please use the project number.
If you wish to participate, please select "yes" from the next two items, one of which is an attestation that you have used galantamine previously, and the next one stipulating your willingness to participate.
If you consent to participate, there will be a brief questionnaire that follows, which will take about five minutes to complete. Thank you--Dr. Scott Sparrow